Literature DB >> 29229503

Characterization of early-onset motor deficits in the Pink1-/- mouse model of Parkinson disease.

Cynthia A Kelm-Nelson1, Alexander F L Brauer2, Kelsey J Barth2, Jacob M Lake2, Mackenzie L K Sinnen3, Forrest J Stehula4, Cagla Muslu3, Roberta Marongiu5, Michael G Kaplitt5, Michelle R Ciucci6.   

Abstract

In Parkinson disease (PD), a complex neurodegenerative disorder that affects nearly 10 million people worldwide, motor skills are significantly impaired. However, onset and progression of motor deficits and the neural correlates of these deficits are poorly understood. We used a genetic mouse model of PD (Pink1-/-), with phenotypic similarities to human PD, to investigate the manifestation of early-onset sensorimotor deficits. We hypothesized this mouse model would show early vocalization and gross motor dysfunction that would be progressive in nature. Pink1-/- mice, compared to wild type (WT) controls, were evaluated at 2, 3, 4, 5, and 6 months of age. To quantify deficit progression, ultrasonic vocalizations and spontaneous locomotor activity (cylinder test and pole test) were analyzed. Although somewhat variable, in general, Pink1-/- mice produced significantly more simple calls with reduced intensity as well as a larger percentage of cycle calls compared to WT counterparts. However, there were no significant differences in duration, bandwidth, or peak frequency for any of the ultrasonic call types between genotypes. Pink1-/- mice showed a significant impairment in limb motor skills with fewer hindlimb steps, forelimb steps, and rears and lands in the cylinder test compared to WT. Additionally, Pink1-/- mice took significantly longer to turn and traverse during the pole test. Immunohistochemical staining showed no significant difference in the number of tyrosine hydroxylase (TH) positive cells in the substantia nigra or density of TH staining in the striatum between genotypes. These data suggest the Pink1-/- mouse model may be instrumental in defining early motor biomarkers of PD in the absence of nigrostriatal dopamine loss. Published by Elsevier B.V.

Entities:  

Keywords:  Mouse; Parkinson disease; Pink1; Ultrasonic vocalization

Mesh:

Substances:

Year:  2017        PMID: 29229503      PMCID: PMC5767140          DOI: 10.1016/j.brainres.2017.12.002

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  52 in total

1.  Pole test is a useful method for evaluating the mouse movement disorder caused by striatal dopamine depletion.

Authors:  K Matsuura; H Kabuto; H Makino; N Ogawa
Journal:  J Neurosci Methods       Date:  1997-04-25       Impact factor: 2.390

2.  Early Expression of Parkinson's Disease-Related Mitochondrial Abnormalities in PINK1 Knockout Rats.

Authors:  Lance M Villeneuve; Phillip R Purnell; Michael D Boska; Howard S Fox
Journal:  Mol Neurobiol       Date:  2014-11-25       Impact factor: 5.590

3.  Stereotypic laryngeal and respiratory motor patterns generate different call types in rat ultrasound vocalization.

Authors:  Tobias Riede
Journal:  J Exp Zool A Ecol Genet Physiol       Date:  2013-02-19

4.  Predictors of deterioration in health-related quality of life in Parkinson's disease: results from the DATATOP trial.

Authors:  Connie Marras; Michael P McDermott; Paula A Rochon; Caroline M Tanner; Gary Naglie; Anthony E Lang
Journal:  Mov Disord       Date:  2008-04-15       Impact factor: 10.338

5.  PINK1/Parkin-mediated mitophagy is dependent on VDAC1 and p62/SQSTM1.

Authors:  Sven Geisler; Kira M Holmström; Diana Skujat; Fabienne C Fiesel; Oliver C Rothfuss; Philipp J Kahle; Wolfdieter Springer
Journal:  Nat Cell Biol       Date:  2010-01-24       Impact factor: 28.824

6.  Evidence for early and progressive ultrasonic vocalization and oromotor deficits in a PINK1 gene knockout rat model of Parkinson's disease.

Authors:  Laura M Grant; Cynthia A Kelm-Nelson; Breanna L Hilby; Katherine V Blue; Eunice S Paul Rajamanickam; Joshua D Pultorak; Shelia M Fleming; Michelle R Ciucci
Journal:  J Neurosci Res       Date:  2015-07-31       Impact factor: 4.164

7.  Early-onset parkinsonism associated with PINK1 mutations: frequency, genotypes, and phenotypes.

Authors:  V Bonifati; C F Rohé; G J Breedveld; E Fabrizio; M De Mari; C Tassorelli; A Tavella; R Marconi; D J Nicholl; H F Chien; E Fincati; G Abbruzzese; P Marini; A De Gaetano; M W Horstink; J A Maat-Kievit; C Sampaio; A Antonini; F Stocchi; P Montagna; V Toni; M Guidi; A Dalla Libera; M Tinazzi; F De Pandis; G Fabbrini; S Goldwurm; A de Klein; E Barbosa; L Lopiano; E Martignoni; P Lamberti; N Vanacore; G Meco; B A Oostra
Journal:  Neurology       Date:  2005-07-12       Impact factor: 9.910

8.  Parkinson phenotype in aged PINK1-deficient mice is accompanied by progressive mitochondrial dysfunction in absence of neurodegeneration.

Authors:  Suzana Gispert; Filomena Ricciardi; Alexander Kurz; Mekhman Azizov; Hans-Hermann Hoepken; Dorothea Becker; Wolfgang Voos; Kristina Leuner; Walter E Müller; Alexei P Kudin; Wolfram S Kunz; Annabelle Zimmermann; Jochen Roeper; Dirk Wenzel; Marina Jendrach; Moisés García-Arencíbia; Javier Fernández-Ruiz; Leslie Huber; Hermann Rohrer; Miguel Barrera; Andreas S Reichert; Udo Rüb; Amy Chen; Robert L Nussbaum; Georg Auburger
Journal:  PLoS One       Date:  2009-06-03       Impact factor: 3.240

9.  The PINK1/Parkin pathway regulates mitochondrial morphology.

Authors:  Angela C Poole; Ruth E Thomas; Laurie A Andrews; Heidi M McBride; Alexander J Whitworth; Leo J Pallanck
Journal:  Proc Natl Acad Sci U S A       Date:  2008-01-29       Impact factor: 11.205

10.  Of mice, birds, and men: the mouse ultrasonic song system has some features similar to humans and song-learning birds.

Authors:  Gustavo Arriaga; Eric P Zhou; Erich D Jarvis
Journal:  PLoS One       Date:  2012-10-10       Impact factor: 3.240

View more
  13 in total

1.  Quantitative Analysis of Catecholamines in the Pink1 -/- Rat Model of Early-onset Parkinson's Disease.

Authors:  Cynthia A Kelm-Nelson; Michael A Trevino; Michelle R Ciucci
Journal:  Neuroscience       Date:  2018-02-27       Impact factor: 3.590

Review 2.  Regulation of Mitochondrial ATP Production: Ca2+ Signaling and Quality Control.

Authors:  Liron Boyman; Mariusz Karbowski; W Jonathan Lederer
Journal:  Trends Mol Med       Date:  2019-11-22       Impact factor: 11.951

3.  Recurrent laryngeal nerve transection in mice results in translational upper airway dysfunction.

Authors:  Megan M Haney; Ali Hamad; Henok G Woldu; Michelle Ciucci; Nicole Nichols; Filiz Bunyak; Teresa E Lever
Journal:  J Comp Neurol       Date:  2019-10-18       Impact factor: 3.215

4.  Early-onset Parkinsonian behaviors in female Pink1-/- rats.

Authors:  Julia M Marquis; Samantha E Lettenberger; Cynthia A Kelm-Nelson
Journal:  Behav Brain Res       Date:  2019-09-19       Impact factor: 3.332

5.  Intestinal infection triggers Parkinson's disease-like symptoms in Pink1-/- mice.

Authors:  Diana Matheoud; Tyler Cannon; Aurore Voisin; Anna-Maija Penttinen; Lauriane Ramet; Ahmed M Fahmy; Charles Ducrot; Annie Laplante; Marie-Josée Bourque; Lei Zhu; Romain Cayrol; Armelle Le Campion; Heidi M McBride; Samantha Gruenheid; Louis-Eric Trudeau; Michel Desjardins
Journal:  Nature       Date:  2019-07-17       Impact factor: 49.962

Review 6.  Genes Implicated in Familial Parkinson's Disease Provide a Dual Picture of Nigral Dopaminergic Neurodegeneration with Mitochondria Taking Center Stage.

Authors:  Rafael Franco; Rafael Rivas-Santisteban; Gemma Navarro; Annalisa Pinna; Irene Reyes-Resina
Journal:  Int J Mol Sci       Date:  2021-04-28       Impact factor: 5.923

Review 7.  Neonatal 6-hydroxydopamine lesioning of rats and dopaminergic neurotoxicity: proposed animal model of Parkinson's disease.

Authors:  Richard M Kostrzewa
Journal:  J Neural Transm (Vienna)       Date:  2022-03-12       Impact factor: 3.850

8.  Phosphorylation of Parkin at serine 65 is essential for its activation in vivo.

Authors:  Thomas G McWilliams; Erica Barini; Risto Pohjolan-Pirhonen; Simon P Brooks; François Singh; Sophie Burel; Kristin Balk; Atul Kumar; Lambert Montava-Garriga; Alan R Prescott; Sidi Mohamed Hassoun; François Mouton-Liger; Graeme Ball; Rachel Hills; Axel Knebel; Ayse Ulusoy; Donato A Di Monte; Jevgenia Tamjar; Odetta Antico; Kyle Fears; Laura Smith; Riccardo Brambilla; Eino Palin; Miko Valori; Johanna Eerola-Rautio; Pentti Tienari; Olga Corti; Stephen B Dunnett; Ian G Ganley; Anu Suomalainen; Miratul M K Muqit
Journal:  Open Biol       Date:  2018-11-07       Impact factor: 6.411

9.  Intraperitoneal Administration of Forskolin Reverses Motor Symptoms and Loss of Midbrain Dopamine Neurons in PINK1 Knockout Rats.

Authors:  Emmanuel Vazquez-Mayorga; Mariana Grigoruta; Raul Dagda; Bridget Martinez; Ruben K Dagda
Journal:  J Parkinsons Dis       Date:  2022       Impact factor: 5.520

10.  Quantification of brainstem norepinephrine relative to vocal impairment and anxiety in the Pink1-/- rat model of Parkinson disease.

Authors:  Jesse D Hoffmeister; Cynthia A Kelm-Nelson; Michelle R Ciucci
Journal:  Behav Brain Res       Date:  2021-08-04       Impact factor: 3.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.